
AsterInsights
@asterinsights
Accelerating oncology medical product discovery and development through our scientific and clinical intelligence.
ID: 1124317926746669056
https://www.asterinsights.com/ 03-05-2019 14:20:57
773 Tweet
238 Followers
438 Following

Chief Fellow Riya Patel, MD proudly sharing her research with Dr. Renuka Iyer at #ASCO24. Using ORIEN data, they uncovered likely biomarkers that can indicate which patients with #cholangiocarcinoma will benefit most from #immunotherapy.



Today at #ASCO24, Dr. Taylor Rives, Markey Cancer Center, presents collaborative #ORIEN research about molecular differences in Kentucky Appalachian populations which may reveal opportunities for treatment and reduce #cancer disparities. More: meetings.asco.org/abstracts-pres… #CollaborativeScience


GYN oncology fellow, Taylor A. Rives, MD, MD found there are genomic differences in #EndometrialCancer of non-Appalachian & Appalachian patients with increased EVI5 mutations, an oncogene in cell cycle regulation. #ASCO24 Markey Cancer Center



Excited to share our latest published article | Differences in Co-Expression of #TCell #CoInhibitory & #CoStimulatory Molecules with #PD1 Across Different Human Cancers | #Immunooncology #DrugDevelopment #ORIEN Moffitt Cancer Center Moffitt Research gavinpublishers.com/article/view/d…


The National Cancer Institute Division of Cancer Control & Population Sciences welcomes Dr. Erin Siegel as the new Associate Director of our Epidemiology & Genomics Research Program! Learn more about Dr. Siegel here: epi.grants.cancer.gov/staff/siegel.h…





Excited to host Dr. Kimryn Rathmell, NCI Director, as our keynote speaker & Dr. Richard Pazdur, Director, FDA Oncology Center of Excellence, for a fireside chat at our 5th annual #ORIEN Scientific Summit this fall! #CollaborativeScience #OncologyResearch



Our latest published article |#Melanoma #tumor #microbiome & #TME #immunogenicity, response & resistance to #immunecheckpoint inhibitors | Great collaboration with Dan Spakowicz, AC Tan #ORIEN #IO team | Moffitt Cancer Center search.app/GSBjn2AWyemYXU…

📝New publication from Dan Spakowicz & the exORIEN Consortium: The tumor #microbiome as a predictor of outcomes in patients with metastatic #melanoma treated with immune checkpoint inhibitors Ahmad Tarhini #ORIEN Cancer Research Communications doi.org/10.1158/2767-9…

#ICYMI: The tumor microbiome as a predictor of outcomes in patients with metastatic melanoma treated with immune checkpoint inhibitors, by Caroline E. Dravillas et al. bit.ly/3Su8pNj Dan Spakowicz Ahmad Tarhini Ohio State Medical Oncology The James Moffitt Cancer Center #openaccess






September is Prostate Cancer Awareness Month – Scientists across ORIEN and Aster Insights are working together, armed with Avatar clinicogenomic data, to unlock the complexities of this disease and improve outcomes for men needing novel therapeutic options. G. Daniel Grass MD, PhD
